The effects of transcription factor overexpression were assessed in vitro via a re-stimulation assay, which involved re-stimulating CAR T cells with E0771-HER2 tumours three times before phenotypic and functional analyses (Extended Data Fig. 3a). This evidence concerns the gene ERBB2 and neoplasm.